In vivo arginine production and intravascular nitric oxide synthesis in hypotensive sepsis

American Journal of Clinical Nutrition

Volumn 84, Issue 1, 2006, Pages 197-203

  Villalpando, Salvador ^a   Gopal, Jayashree ^b,d   Balasubramanyam, Ashok ^b,d   Bandi, Venkata P ^c,d   Guntupalli, Kalpalatha ^c,d   Jahoor, Farook ^a,c  

^a CHILDREN S NUTRITION RESEARCH CENTER   (United States)

^b Department of Medicine   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d BEN TAUB GENERAL HOSPITAL   (United States)

Author keywords

Arginine; Hypotensive sepsis; Kinetics; Nitric oxide; Renal function; Stable isotope

Indexed keywords

ARGININE; ARGININE DERIVATIVE; CREATININE; NITRATE; NITRIC OXIDE; NITRITE; UNCLASSIFIED DRUG; [N2 GUANIDINO]ARGININE; NITROGEN;

ADULT; AGED; AMINO ACID BLOOD LEVEL; AMINO ACID METABOLISM; AMINO ACID SYNTHESIS; ARTICLE; BIOSYNTHESIS; BLOOD ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HYPOTENSION; IN VIVO STUDY; MALE; SEPSIS; SEPTIC SHOCK; URINARY EXCRETION; BLOOD; CASE CONTROL STUDY; CRITICAL ILLNESS; GLOMERULUS FILTRATION RATE; METABOLISM; MIDDLE AGED;

ADULT; AGED; ARGININE; CASE-CONTROL STUDIES; CRITICAL ILLNESS; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; HYPOTENSION; MALE; MIDDLE AGED; NITRATES; NITRIC OXIDE; NITRITES; NITROGEN ISOTOPES; SHOCK, SEPTIC;

EID: 33747410883     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/84.1.197     Document Type: Article

References (35)

1. Tapiero H, Mathe G, Couvreur P, Tew KD. I. Arginine. Biomed Pharmacother 2002;56:439-45.
2. Daly JM, Reynolds J, Thom A, et al. Immune and metabolic effects of arginine in the surgical patient. Ann Surg 1988;208:512-23.
3. Reynolds JV, Daly JM, Shou J, Sigal R, Ziegler MM, Naji A. Immunologic effects of arginine supplementation in tumor-bearing and nontumor-bearing hosts. Ann Surg 1990;211:202-10.
4. Suchner U, Heyland DK, Peter K. Immune-modulatory actions of arginine in the critically ill. Br J Nutr 2002;87(suppl):S121-32.
5. Freund H, Atamian S, Holroyde J, Fischer JE. Plasma amino acids as predictors of the severity and outcome of sepsis. Ann Surg 1979;190:571-6.
6. Argaman Z, Young VR, Noviski N, et al. Arginine and nitric oxide metabolism in critically ill septic pediatric patients. Crit Care Med 2003;31:591-7.
7. Higashi Y, Oshima T, Ozono R, Matsuura H, Kambe M, Kajiyama G. Effect of L-arginine infusion on systemic and renal hemodynamics in hypertensive patients. Am J Hypertens 1999;12:8-15.
8. Landry DW, Oliver JA. The pathogenesis of vasodilatory shock. N Engl J Med 2001;345:588-95.
9. de Werra I, Jaccard C, Corradin SB, et al. Cytokines, nitrite/nitrate, soluble tumor necrosis factor receptors, and procalcitonin concentrations: comparisons in patients with septic shock, cardiogenic shock, and bacterial pneumonia. Crit Care Med 1997;25:607-13.
10. Ochoa JB, Udekwu AO, Billiar TR, et al. Nitrogen oxide levels in patients after trauma and during sepsis. Ann Surg 1991;214:621-6.
11. Macnaul KL, Hutchinson NI. Differential expression of iNOS and cNOS mRNA in human vascular smooth muscle cells and endothelial cells under normal and inflammatory conditions. Biochem Biophys Res Commun 1993;196:1330-4.
12. Thiemermann C, Szabo C, Mitchell JA, Vane JR. Vascular hyporeactivity to vasoconstrictor agents and hemodynamic decompensation in hemorrhagic shock is mediated by nitric oxide. Proc Natl Acad Sci U S A 1993;90:267-71.
13. Grover R, Zaccardelli D, Colice G, Guntupalli K, Watson D, Vincent JL. An open-label dose escalation study of the nitric oxide synthase inhibitor, N(G)-methyl-L-arginine hydrochloride (546C88), in patients with septic shock. Glaxo Wellcome International Septic Shock Study Group. Crit Care Med 1999;27:913-22.
14. Harbrecht BG, Wu B, Watkins SC, Billiar TR, Peitzman AB. Inhibition of nitric oxide synthesis during severe shock but not after resuscitation increases hepatic injury and neutrophil accumulation in hemorrhaged rats. Shock 1997;8:415-21.
15. Kilbourn R. Nitric oxide synthase inhibitors - a mechanism-based treatment of septic shock. Crit Care Med 1999;27:857-8.
16. Leaf CD, Wishnok JS, Tannenbaum SR. L-Arginine is a precursor for nitrate biosynthesis in humans. Biochem Biophys Res Commun 1989;163:1032-7.
17. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992;101:1644-55.
18. 15N-labelled analogs. J Chromatogr B Biomed Appl 1994;661:185-91.
19. Tsikas D. Simultaneous derivatization and quantification of the nitric oxide metabolites nitrite and nitrate in biological fluids by gas chromatography/ mass spectrometry. Anal Chem 2000;72:4064-72.
20. Goodrum L, Saade GR, Belfort MA, Moise KJ Jr, Jahoor F. Arginine flux and nitric oxide production during human pregnancy and postpartum. J Soc Gynecol Investig 2003;10:400-5.
21. Kirk SJ, Barbul A. Role of arginine in trauma, sepsis, and immunity. JPEN J Parenter Enteral Nutr 1990;14:226S-9S.
22. Barbul A. Arginine: biochemistry, physiology, and therapeutic implications. JPEN J Parenter Enteral Nutr 1986;10:227-38.
23. Castillo L, Yu YM, Marchini JS, et al. Phenylalanine and tyrosine kinetics in critically ill children with sepsis. Pediatr Res 1994;35:580-8.
24. Gore DC, Jahoor F, Wolfe RR, Herndon DN. Acute response of human muscle protein to catabolic hormones. Ann Surg 1993;218:679-84.
25. Luiking YC, Poeze M, Dejong CH, Ramsay G, Deutz NE. Sepsis: an arginine deficiency state? Crit Care Med 2004;32:2135-45.
26. Evans T, Carpenter A, Kinderman H, Cohen J. Evidence of increased nitric oxide production in patients with the sepsis syndrome. Circ Shock 1993;41:77-81.
27. Nijveldt RJ, Teerlink T, Van Der Hoven B, et al. Asymmetrical dimethylarginine (ADMA) in critically ill patients: high plasma ADMA concentration is an independent risk factor of ICU mortality. Clin Nutr 2003;2:23-30.
28. Nijveldt RJ, Siroen MP, Teerlink T, van Lambalgen AA, Rauwerda JA, van Leeuwen PA. Gut and liver handling of asymmetric and symmetric dimethylarginine in the rat under basal conditions and during endotoxemia. Liver Int 2004;24:510-8.
29. Nijveldt RJ, Siroen MP, Teerlink T, van Leeuwen PA. Elimination of asymmetric dimethylarginine by the kidney and the liver: a link to the development of multiple organ failure? J Nutr 2004;134(suppl):2848S-52S.
30. Kilbourn RG, Griffith OW. Overproduction of nitric oxide in cytokine-mediated and septic shock. J Natl Cancer Inst 1992;84:827-31.
31. Cohen J, Silva A. NO inhibitors and septic shock. Lancet 1992;339:751.
32. Petros A, Bennett D, Vallance P. Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet 1991;338:1557-8.
33. Gmonomethyl-L- arginine inhibits endotoxin-induced nitrate/nitrate biosynthesis while promoting hepatic damage. J Leukoc Biol 1990;48:565-9.
34. Bruins MJ, Soeters PB, Lamers WH, Meijer AJ, Deutz NE. L-Arginine supplementation in hyperdynamic endotoxemic pigs: effect on nitric oxide synthesis by the different organs. Crit Care Med 2002;30:508-17.
35. Lauer T, Kleinbongard P, Kelm M. Indexes of NO bioavailability in human blood. News Physiol Sci 2002;17:251-5.